Logo image of PRTG

PORTAGE BIOTECH INC (PRTG) Stock Overview

USA - NASDAQ:PRTG - VGG7185A1369 - Common Stock

6.81 USD
-0.15 (-2.16%)
Last: 9/3/2025, 8:00:01 PM
7.4101 USD
+0.6 (+8.81%)
After Hours: 9/3/2025, 8:00:01 PM

PRTG Key Statistics, Chart & Performance

Key Statistics
Market Cap15.53M
Revenue(TTM)N/A
Net Income(TTM)-6767000
Shares2.28M
Float900.00K
52 Week High23.01
52 Week Low2.81
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-5.72
PEN/A
Fwd PEN/A
Earnings (Next)11-24 2025-11-24
IPO2013-10-28
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


PRTG short term performance overview.The bars show the price performance of PRTG in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40

PRTG long term performance overview.The bars show the price performance of PRTG in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 50 -50 100

The current stock price of PRTG is 6.81 USD. In the past month the price decreased by -2.99%. In the past year, price increased by 129.29%.

PORTAGE BIOTECH INC / PRTG Daily stock chart

PRTG Latest News, Press Relases and Analysis

PRTG Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.91 409.95B
AMGN AMGEN INC 13.91 163.30B
GILD GILEAD SCIENCES INC 15.91 152.76B
VRTX VERTEX PHARMACEUTICALS INC 24.74 107.45B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 64.39B
REGN REGENERON PHARMACEUTICALS 12.64 61.13B
ARGX ARGENX SE - ADR 92.23 52.30B
INSM INSMED INC N/A 35.49B
ONC BEONE MEDICINES LTD-ADR 5.15 34.99B
BNTX BIONTECH SE-ADR N/A 25.95B
NTRA NATERA INC N/A 25.89B
BIIB BIOGEN INC 9.16 21.50B

About PRTG

Company Profile

PRTG logo image Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. The firm is engaged in advancing therapies to improve long-term treatment, response, and quality of life in patients with cancers. The Company’s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through the translational pipeline. Its adenosine antagonist platform include PORT-9 and PORT-8. PORT-9 and PORT-8 are in the preclinical stage. Its PORT-8 is a dual inhibitor of adenosine receptors 2A and 2B (A2A/A2B) to address solid tumors. Its PORT-9 is an A2B antagonist designed to treat colorectal and gastrointestinal cancers. Its iNKT Engager platform includes PORT- 3, which is in Phase I.

Company Info

PORTAGE BIOTECH INC

Clarence Thomas Building, P.O. Box 4649, Road Town

Tortola ONTARIO VG1110 VG

CEO: Ian Walters

Employees: 4

PRTG Company Website

PRTG Investor Relations

Phone: 4167377600

PORTAGE BIOTECH INC / PRTG FAQ

What is the stock price of PORTAGE BIOTECH INC today?

The current stock price of PRTG is 6.81 USD. The price decreased by -2.16% in the last trading session.


What is the ticker symbol for PORTAGE BIOTECH INC stock?

The exchange symbol of PORTAGE BIOTECH INC is PRTG and it is listed on the Nasdaq exchange.


On which exchange is PRTG stock listed?

PRTG stock is listed on the Nasdaq exchange.


What is PORTAGE BIOTECH INC worth?

PORTAGE BIOTECH INC (PRTG) has a market capitalization of 15.53M USD. This makes PRTG a Nano Cap stock.


How many employees does PORTAGE BIOTECH INC have?

PORTAGE BIOTECH INC (PRTG) currently has 4 employees.


What are the support and resistance levels for PORTAGE BIOTECH INC (PRTG) stock?

PORTAGE BIOTECH INC (PRTG) has a support level at 6.8 and a resistance level at 6.82. Check the full technical report for a detailed analysis of PRTG support and resistance levels.


Should I buy PORTAGE BIOTECH INC (PRTG) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PORTAGE BIOTECH INC (PRTG) stock pay dividends?

PRTG does not pay a dividend.


When does PORTAGE BIOTECH INC (PRTG) report earnings?

PORTAGE BIOTECH INC (PRTG) will report earnings on 2025-11-24.


What is the Price/Earnings (PE) ratio of PORTAGE BIOTECH INC (PRTG)?

PORTAGE BIOTECH INC (PRTG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.72).


PRTG Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to PRTG. When comparing the yearly performance of all stocks, PRTG is one of the better performing stocks in the market, outperforming 92.16% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

PRTG Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to PRTG. PRTG has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PRTG Financial Highlights

Over the last trailing twelve months PRTG reported a non-GAAP Earnings per Share(EPS) of -5.72. The EPS increased by 92.66% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -304.13%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%75.91%
Sales Q2Q%N/A
EPS 1Y (TTM)92.66%
Revenue 1Y (TTM)N/A

PRTG Forecast & Estimates


Analysts
Analysts43.33
Price TargetN/A
EPS Next Y0%
Revenue Next YearN/A

PRTG Ownership

Ownership
Inst Owners2.21%
Ins Owners35.54%
Short Float %N/A
Short RatioN/A